/home/u169913881/domains/bolanlemedia.com/public_html/wp-content/themes/zox-news/amp-single.php on line 77

Warning: Trying to access array offset on value of type bool in /home/u169913881/domains/bolanlemedia.com/public_html/wp-content/themes/zox-news/amp-single.php on line 77
" width="36" height="36">

World News

Isomorphic inks deals with Eli Lilly and Novartis for drug discovery on January 7, 2024 at 5:51 pm

Published

2 years ago

on

Isomorphic Labs, the London-based, drug discovery-focused spin-out of Google AI R&D division DeepMind, today announced that it’s entered into strategic partnerships with two pharmaceutical giants, Eli Lilly and Novartis, to apply AI to discover new medications to treat diseases. The deals have a combined value of around $3 billion. Isomorphic will receive $45 million upfront […]

© 2023 TechCrunch. All rights reserved. For personal use only.

​ Isomorphic Labs, the London-based, drug discovery-focused spin-out of Google AI R&D division DeepMind, today announced that it’s entered into strategic partnerships with two pharmaceutical giants, Eli Lilly and Novartis, to apply AI to discover new medications to treat diseases. The deals have a combined value of around $3 billion. Isomorphic will receive $45 million upfront
© 2023 TechCrunch. All rights reserved. For personal use only. 

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version